1.05 g of 3-piperidinemethanol was added to a 100-mL round-bottomed flask, and 19.0 mL of tetrahydrofuran and 19.0 mL of saturated sodium hydrogen carbonate (NaHCO3) solution were added thereinto. After 1.19 g of di-tert-butyl dicarbamate (Boc2O) was added thereinto, the reaction mixture was stirred for about 48 hours and then refluxed for about 24 hours. 2.53 mL of triethylamine was added into the reaction mixture and then stirred at room temperature for about 1 hour. The aqueous phase was extracted with 20.0 mL of ethyl acetate (EtOAc) to collect an organic phase. The collected organic phase was washed with 10.0 mL of deionized water and 15.0 mL of saturated brine. The organic phase was then filtered with sodium sulfate (Na2SO4). The resulting filtrate was distilled under reduced pressure, and then the resulting residue was purified by flash column chromatography (MeOH:CH2Cl2=0:100→1:80→1:50). As a result, 964 mg of tert-butyl-3-(hydroxymethyl)piperidine-1-carboxylate was obtained with a yield of about 49.0%.
307 mg of 6-chloro-7-deazapurine was added to a 50-mL round-bottomed flask, and 4.00 mL of N,N-dimethylformamide was added thereinto. After 132 mg of sodium hydride (60wt%) was added thereto at about 0°C, the reaction mixture was stirred at room temperature for about 20 minutes. Then, 0.370 mL of 2-(trimethylsillyl)ethoxymethyl chloride was added thereinto, the reaction mixture was stirred at room temperature for about 1 hour and concentrated under reduced pressure. The reaction mixture was extracted with 5.00 mL of ethyl acetate (EtOAc) and 5.00 mL of deionized water to collect an organic phase. The organic phase was filtered with magnesium sulfate (MgSO4). The resulting filtrate was distilled under reduced pressure. As a result, 252 mg of 4-chloro-7-((2-(trimethylsillyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine was obtained with a yield of about 45.0%.
192 mg of tert-butyl 3-(hydroxymethyl)piperidine-1-carboxylate was added to a 50-mL round-bottomed flask, and 2.50 mL of dimethyl sulfoxide (DMSO) was added thereinto. After 53.4 mg of sodium hydride (60wt%) was added thereinto at about 0°C, the reaction mixture was stirred at room temperature for about 1.5 hour. Then, a solution of 252 mg of 4-chloro-7-((2-(trimethylsillyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine in 2.00 mL of dimethyl sulfoxide (DMSO) was slowly dropwise added thereinto, the reaction mixture was stirred at about 50°C for about 2 hours and then cooled down to room temperature. Then, the reaction mixture was extracted with 10.0 mL of ethyl acetate (EtOAc) and 10.0 mL of deionized water to collect an organic phase. The organic phase was filtered with sodium sulfate (Na2SO4). The resulting filtrate was distilled under reduced pressure, and then the resulting residue was purified by flash column chromatography (MeOH:CH2Cl2=0:100→1:80→1:50). As a result, 282 mg of tert-butyl-3-(((7-((2-(trimethylsillyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine-4-yl)oxy)methyl)piperidine-1-carboxylate was obtained with a yield of about 71.0%.
280 mg of tert-butyl 3-(((7-((2-(trimethylsillyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine-4-yl)oxy)methyl)piperidine-1-carboxylate was added to a 50-mL round-bottomed flask, and then 3.00 mL of tetrahydrofuran was added thereto. After 6.20 mL of a solution of 1.0 M tetrabutylammonium fluoride in tetrahydrofuran was added into the reaction mixture over about 2 hours, the reaction mixture was stirred at room temperature for about 24 hours and then concentrated under reduced pressure. The reaction mixture was extracted with 100 mL of ethyl acetate (EtOAc) and 100 mL of deionized water to collect an organic phase. The organic phase was filtered with sodium sulfate (Na2SO4). The resulting filtrate was distilled under reduced pressure, and then the resulting residue was purified by flash column chromatography (MeOH:CH2Cl2=0:100→1:80→1:50). As a result, 120 mg of tert-butyl-3-(((7H-pyrrolo[2,3-d]pyrimidine-4-yl)oxy)methyl)piperidine-1-carboxylate was obtained with a yield of about 58.0%.
203 mg of tert-butyl-3-(((7H-pyrrolo[2,3-d]pyrimidine-4-yl)oxy)methyl)piperidine-1-carboxylate was added to a 50-mL round-bottomed flask, and then 2.00 mL of 1,4-dioxane was added thereinto. After 4.00 mL of 4N HCI solution was added into the reaction mixture, the reaction mixture was stirred at room temperature for about 2 hours. Then, the reaction mixture was distilled under reduced pressure. Then, 10.0 mL of ethyl acetate (EtOAc) was added into the reaction mixture, and 10.0 mL of a 10% ammonium hydroxide solution was added to basify the reaction mixture (pH=10). An organic phase was filtered with sodium sulfate (Na2SO4). The resulting filtrate was distilled under reduced pressure. As a result, 141 mg of 4-(piperidine-3-ylmethoxy)-7H-pyrrolo[2,3-d]pyrimidine was obtained with a yield of about 61%.
140 mg of 4-(piperidine-3-ylmethoxy)-7H-pyrrolo[2,3-d]pyrimidine was added to a 25-mL round-bottomed flask, and then dissolved with 2.50 mL of dichloromethane (CH2Cl2). After 0.0710 mL of chloroacetyl chloride was added into the solution, the reaction mixture was treated with 0.250 mL of N,N-diisopropylethylamine and then stirred at room temperature for about 1 hour. The reaction mixture was concentrated under reduced pressure, and then the resulting residue was purified by flash column chromatography (MeOH:CH2Cl2=0.100→1:80→1:50). The resulting fraction was concentrated under reduced pressure and then further under vacuum. As a result, 54.9 mg of 1-(3-(((7H-pyrrolo[2,3-d]pyrimidine-4-yl)oxy)methyl)piperidine-1-yl)-2-chloroethane-1-one was obtained with a yield of about 30.0%.
54.9 mg of 1-(3-(((7H-pyrrolo[2,3-d]pyrimidine-4-yl)oxy)methyl)piperidine-1-yl)-2-chloroethane-1-one was added to a 5-mL round-bottomed flask, and then dissolved with 1.10 mL of N,N-dimethylformamide. After 22.4 mg of potassium cyanide was added into the solution, the reaction mixture was stirred at about 30°C to 40°C for about 1 hour. After the reaction mixture was concentrated under reduced pressure, 5.00 mL of deionized water and 5.00 mL of dichloromethane (CH2Cl2) were added into the resulting residue and then stirred for about 5 minutes. An organic phase was separated and concentrated under reduced pressure, and then the resulting residue was purified by flash column chromatography (MeOH:CH2Cl2=0:100→1:80→1:50). The resulting fraction was concentrated under reduced pressure and then further under vacuum. As a result, 34.4 mg of 3-(3-(((7H-pyrrolo[2,3-d]pyrimidine-4-yl)oxy)methyl)piperidine-1-yl)-3-oxopropanenitrile was obtained with a yield of about 64.0 %.